Publish With DrugPatentWatch
Share your expertise with our expansive network > Go to submission form
Share your expertise with our expansive network > Go to submission form
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below.
Addressing the Challenges of Pharmaceutical Distribution in the United States Read Post »
As prescription drug costs continue to squeeze state budgets, a group of state health policy makers is offering some novel
Treat pharma as a utility, and 10 other ways states can lower drug prices Read Post »
This is a guest post from Edward Simpson, a seasoned calibration and technical engineer. Do you have a response to
Process Validation and Its Need in the Biotechnology Industry Read Post »
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below.
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below.
Formulary Best Practice: Cost Containment through Generic Drugs Read Post »
This is a guest post from Brannon Cashion, President of Addison Whitney Health. Do you have a response to Brannin’s post?
Branding Biotech – Communicating the Brand’s Point of Differentiation Read Post »
This is a guest post from Robert Yapundich, MD and Gregory Schimizzi, MD. Dr. Yapundich is a practicing neurologist in Hickory, North Carolina and a
Biosimilar Naming: Distinguishable or Disingenuous? Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
This paper is a final project from the NIH Foundation for Advanced Education in the Sciences course — TECH 566: Biotechnology